Singaporean firm UltraGreen.ai records significant first-half profit surge

UltraGreen.ai, a Singapore-based company, has announced a 45 percent growth in profit for the first half of the current year. This financial performance marks a notable increase for the firm as it continues to expand its footprint in Southeast Asia.

According to the original publisher, the company’s recent financial success coincides with securing important regulatory milestones for its medical technology portfolio. These approvals are expected to facilitate broader market access for the firm’s specialised systems across multiple jurisdictions.

The company confirmed that it has received official regulatory clearance for its Verdye product in the Philippines. This approval allows the firm to introduce its diagnostic solutions to the Philippine healthcare market, representing a strategic step in its international growth strategy.

Simultaneously, the firm has received regulatory approval for its IC-Flow Imaging System V2 in Malaysia. This development is particularly significant for the Malaysian medical sector, as it introduces new diagnostic imaging capabilities to local healthcare facilities and clinics.

These advancements in regulatory status indicate that UltraGreen.ai is prioritising the deployment of its advanced technology within the ASEAN region. For Malaysian stakeholders, the entry of the IC-Flow Imaging System V2 signals an expansion in the availability of diagnostic tools, potentially influencing local healthcare standards and the adoption of modern imaging technology. The combination of strong financial results and successful product licensing positions the firm to further scale its operations in the coming months.